Relistor Alternatives Compared
Relistor | Movantik | Methylnaltrexone |
|
---|
Relistor (methylnaltrexone) | Movantik (naloxegol) | Methylnaltrexone |
|
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Opioid-Induced Constipation, Constipation - Chronic, Constipation - Drug Induced. Relistor may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Opioid-Induced Constipation, Constipation - Chronic, Constipation - Drug Induced. Movantik may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Opioid-Induced Constipation, Constipation - Chronic, Constipation, Constipation - Drug Induced. methylnaltrexone may also be used for purposes not listed in this medication guide. |
Related suggestions Constipation, Drug Induced
Opioid-Induced Constipation
Constipation, Chronic
Popular comparisons
|
|||||||||||||||
More about Relistor (methylnaltrexone) | More about Movantik (naloxegol) | More about Methylnaltrexone | ||||||||||||||||
Ratings & Reviews | ||||||||||||||||||
Relistor has an average rating of 6.4 out of 10 from a total of 60 ratings on Drugs.com. 60% of reviewers reported a positive effect, while 33% reported a negative effect. |
Movantik has an average rating of 4.9 out of 10 from a total of 263 ratings on Drugs.com. 37% of reviewers reported a positive effect, while 48% reported a negative effect. |
Methylnaltrexone has an average rating of 6.5 out of 10 from a total of 63 ratings on Drugs.com. 59% of reviewers reported a positive effect, while 32% reported a negative effect. |
||||||||||||||||
Drug Class | ||||||||||||||||||
Side Effects | ||||||||||||||||||
See also: Relistor side effects in more detail. |
See also: Movantik side effects in more detail. |
See also: methylnaltrexone side effects in more detail. |
||||||||||||||||
Generic Availability | ||||||||||||||||||
N/A |
||||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
View all Relistor prices |
View all Movantik prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||||||||||
Dosage Form(s) Available | ||||||||||||||||||
|
|
N/A |
||||||||||||||||
Brand Names | ||||||||||||||||||
N/A |
N/A |
Relistor | ||||||||||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||
8 hours |
11 hours |
8 hours |
||||||||||||||||
CSA Schedule ** View glossary of terms | ||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
Pregnancy Category | ||||||||||||||||||
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
||||||||||||||||
Drug Interactions | ||||||||||||||||||
A total of 21 drugs are known to interact with Relistor:
|
A total of 203 drugs are known to interact with Movantik:
|
A total of 21 drugs are known to interact with methylnaltrexone:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
|
|
|
||||||||||||||||
Disease Interactions | ||||||||||||||||||
First Approval Date | ||||||||||||||||||
April 24, 2008 |
September 16, 2014 |
April 24, 2008 |
||||||||||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||
More Information | ||||||||||||||||||
Patient resources | ||||||||||||||||||
Professional Resources | ||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.